Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)
China
· Delayed Price · Currency is CNY
8.78
+0.04 (0.46%)
Nov 21, 2024, 9:42 AM CST
Tonghua Dongbao Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 16,940 | 21,483 | 18,210 | 22,161 | 26,999 | 25,730 | Upgrade
|
Market Cap Growth | -18.34% | 17.97% | -17.83% | -17.92% | 4.93% | -8.99% | Upgrade
|
Enterprise Value | 17,065 | 20,921 | 16,966 | 21,321 | 26,741 | 25,526 | Upgrade
|
Last Close Price | 8.69 | 10.56 | 8.75 | 9.86 | 11.83 | 11.04 | Upgrade
|
PE Ratio | 54.45 | 18.40 | 11.51 | 16.94 | 29.03 | 31.72 | Upgrade
|
Forward PE | 23.17 | 20.43 | 16.39 | 23.83 | 25.47 | 24.98 | Upgrade
|
PS Ratio | 7.64 | 6.99 | 6.55 | 6.78 | 9.34 | 9.26 | Upgrade
|
PB Ratio | 2.64 | 2.98 | 2.78 | 3.56 | 4.86 | 5.14 | Upgrade
|
P/TBV Ratio | 2.99 | 3.28 | 3.01 | 3.80 | 5.10 | 5.42 | Upgrade
|
P/FCF Ratio | 227.34 | 41.84 | 49.19 | 38.23 | 37.88 | 29.95 | Upgrade
|
P/OCF Ratio | 28.33 | 24.94 | 21.10 | 18.77 | 22.65 | 22.33 | Upgrade
|
PEG Ratio | 2.11 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | Upgrade
|
EV/Sales Ratio | 7.02 | 6.80 | 6.11 | 6.52 | 9.25 | 9.19 | Upgrade
|
EV/EBITDA Ratio | 22.21 | 14.38 | 16.42 | 15.35 | 20.58 | 23.31 | Upgrade
|
EV/EBIT Ratio | 30.57 | 16.47 | 19.23 | 17.12 | 23.36 | 27.09 | Upgrade
|
EV/FCF Ratio | 229.01 | 40.75 | 45.83 | 36.78 | 37.52 | 29.71 | Upgrade
|
Debt / Equity Ratio | 0.08 | 0.02 | 0.00 | 0.00 | 0.00 | 0.03 | Upgrade
|
Debt / EBITDA Ratio | 0.64 | 0.10 | 0.00 | 0.00 | 0.00 | 0.12 | Upgrade
|
Debt / FCF Ratio | 6.61 | 0.29 | 0.01 | 0.00 | 0.00 | 0.15 | Upgrade
|
Asset Turnover | 0.34 | 0.42 | 0.42 | 0.53 | 0.52 | 0.51 | Upgrade
|
Inventory Turnover | 0.74 | 0.91 | 1.05 | 1.09 | 1.00 | 0.95 | Upgrade
|
Quick Ratio | 2.32 | 3.92 | 8.16 | 5.81 | 6.40 | 4.16 | Upgrade
|
Current Ratio | 4.30 | 5.41 | 12.69 | 8.05 | 9.23 | 6.32 | Upgrade
|
Return on Equity (ROE) | 5.14% | 16.97% | 24.77% | 22.22% | 17.61% | 16.62% | Upgrade
|
Return on Assets (ROA) | 4.87% | 10.93% | 8.31% | 12.63% | 12.83% | 10.89% | Upgrade
|
Return on Capital (ROIC) | 5.02% | 11.41% | 8.63% | 13.21% | 13.37% | 11.41% | Upgrade
|
Earnings Yield | 1.84% | 5.44% | 8.69% | 5.90% | 3.44% | 3.15% | Upgrade
|
FCF Yield | 0.44% | 2.39% | 2.03% | 2.62% | 2.64% | 3.34% | Upgrade
|
Dividend Yield | 2.86% | 2.37% | 5.72% | 3.04% | 1.77% | 1.81% | Upgrade
|
Payout Ratio | 147.41% | 42.49% | 69.27% | 32.49% | 43.40% | 50.15% | Upgrade
|
Buyback Yield / Dilution | -6.93% | 1.15% | 2.04% | -1.12% | 0.32% | 0.85% | Upgrade
|
Total Shareholder Return | -4.07% | 3.52% | 7.76% | 1.93% | 2.09% | 2.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.